CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-07 | COMMODORE CAPITAL LP 10% owner | Purchase | +775,756 | $23.15 | $18.0M | 1,575,000 |
| 2022-08-18 | GIN JERRY B Director | Purchase | +100,000 | $0.18 | $18K | 100,000 |
| 2022-08-18 | GIN JERRY B Director | Purchase | +100,000 | $0.18 | $18K | 100,000 |
| 2022-08-17 | Adler Reid G. CHIEF LEGAL OFFICER | Purchase | +300,000 | $0.17 | $51K | 334,629 |
| 2022-08-17 | Singh Shawn CHIEF EXECUTIVE OFFICER | Purchase | +600,000 | $0.17 | $103K | 626,234 |
| 2021-08-17 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Purchase | +3,750 | $2.73 | $10K | 34,641 |
| 2020-08-21 | SAXE JON S Director | Purchase | +30,000 | $0.69 | $21K | 50,000 |
| 2019-11-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Purchase | +15,000 | $0.34 | $5K | 15,000 |
| 2019-03-14 | SAXE JON S Director | Purchase | +7,920 | $1.27 | $10K | 20,000 |
| 2019-03-13 | SAXE JON S Director | Purchase | +12,080 | $1.26 | $15K | 12,080 |
| 2017-05-31 | GIN JERRY B Director | Purchase | +50,000 | 50,000 | ||
| 2017-05-31 | GIN JERRY B Director | Purchase | +50,000 | 100,000 |
Page 1 of 1 · 12 trades